Healthcare Global Enterprises Limited (NSE:HCG) — Market Cap & Net Worth

$873.06 Million USD  · Rs80.73 Billion INR  · Rank #9729

Market Cap & Net Worth: Healthcare Global Enterprises Limited (HCG)

Healthcare Global Enterprises Limited (NSE:HCG) has a market capitalization of $873.06 Million (Rs80.73 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #9729 globally and #456 in its home market, demonstrating a -0.99% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Healthcare Global Enterprises Limited's stock price Rs572.55 by its total outstanding shares 141000100 (141.00 Million). Analyse how efficiently does Healthcare Global Enterprises Limited generate cash to see how efficiently the company converts income to cash.

Healthcare Global Enterprises Limited Market Cap History: 2016 to 2026

Healthcare Global Enterprises Limited's market capitalization history from 2016 to 2026. Data shows growth from $377.40 Million to $873.06 Million (12.72% CAGR).

Index Memberships

Healthcare Global Enterprises Limited is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NIFTY MICROCAP 250
NIFTYMICROCAP250
$143.76 Billion 0.61% #51 of 250
NIFTY TOTAL MARKET
NIFTYTOTALMKT
$3.20 Trillion 0.03% #376 of 750

Weight: Healthcare Global Enterprises Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Healthcare Global Enterprises Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Healthcare Global Enterprises Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.05x

Healthcare Global Enterprises Limited's market cap is 0.05 times its annual revenue

Industry average: 0.62x Lower than industry average

Latest Price to Earnings (P/E) Ratio

2.27x

Healthcare Global Enterprises Limited's market cap is 2.27 times its annual earnings

Industry average: 16.44x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $377.40 Million $5.84 Billion -$14.61 Million 0.06x N/A
2017 $426.66 Million $7.00 Billion $221.73 Million 0.06x 1.92x
2018 $298.19 Million $8.31 Billion $205.23 Million 0.04x 1.45x
2019 $159.20 Million $9.79 Billion -$247.97 Million 0.02x N/A
2020 $248.17 Million $10.96 Billion -$1.07 Billion 0.02x N/A
2021 $364.14 Million $10.13 Billion -$1.93 Billion 0.04x N/A
2022 $438.32 Million $13.98 Billion $537.33 Million 0.03x 0.82x
2023 $557.34 Million $16.94 Billion $293.49 Million 0.03x 1.90x
2024 $745.89 Million $19.12 Billion $481.55 Million 0.04x 1.55x
2025 $1.01 Billion $22.23 Billion $444.10 Million 0.05x 2.27x

Competitor Companies of HCG by Market Capitalization

Companies near Healthcare Global Enterprises Limited in the global market cap rankings as of May 4, 2026.

Key companies related to Healthcare Global Enterprises Limited by market ranking:

  • HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
  • Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
  • FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
  • IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#256 HCA Holdings Inc NYSE:HCA $96.85 Billion $433.09
#962 Fresenius SE & Co. KGaA XETRA:FRE $27.16 Billion €41.25
#972 FRESENIUS SE+CO. ADR 1/4 F:FREA $26.87 Billion €10.20
#1292 IHH Healthcare Bhd KLSE:5225 $19.57 Billion RM8.82

Healthcare Global Enterprises Limited Historical Marketcap From 2016 to 2026

Between 2016 and today, Healthcare Global Enterprises Limited's market cap moved from $377.40 Million to $ 873.06 Million, with a yearly change of 12.72%.

Year Market Cap Change (%)
2026 Rs873.06 Million -13.51%
2025 Rs1.01 Billion +35.34%
2024 Rs745.89 Million +33.83%
2023 Rs557.34 Million +27.15%
2022 Rs438.32 Million +20.37%
2021 Rs364.14 Million +46.73%
2020 Rs248.17 Million +55.89%
2019 Rs159.20 Million -46.61%
2018 Rs298.19 Million -30.11%
2017 Rs426.66 Million +13.05%
2016 Rs377.40 Million --

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of Healthcare Global Enterprises Limited was reported to be:

Source Market Cap
Yahoo Finance $873.06 Million USD
MoneyControl $873.06 Million USD
MarketWatch $873.06 Million USD
marketcap.company $873.06 Million USD
Reuters $873.06 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Healthcare Global Enterprises Limited

NSE:HCG India Medical Care Facilities
Market Cap
$873.06 Million
Rs80.73 Billion INR
Market Cap Rank
#9729 Global
#456 in India
Share Price
Rs572.55
Change (1 day)
+0.39%
52-Week Range
Rs521.75 - Rs776.30
All Time High
Rs776.30
About

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more